biostudies-literatureTerry-McElrath YMNIDA NIH HHSNational Institute on Drug Abuse107994https://www.ebi.ac.uk/biostudies/studies/S-EPMC12814403biostudies-literatureUnknown70(3)<h4>Introduction</h4>This study provides national data on cannabis use type (medical versus recreational only) across individuals aged 19-65 years and associations with overall cannabis use prevalence and frequency, including developmental and historical trends and sociodemographic and policy associations.<h4>Methods</h4>Data collected in 2018-2023 from individuals (N=33,647) aged 19-65 years participating in the Monitoring the Future Panel study were analyzed in 2024-2025. Developmental and historical trends and regression analyses examined past 12-month cannabis use type: no use, recreational-only use, or any medical cannabis used from their own written medical recommendation/prescription (with or without recreational use).<h4>Results</h4>Medical use was reported by 2.6% (2.3%, 2.8%) of American journal of preventive medicineMedical Cannabis Use Across Ages 19-65 Years: U.S. Young and Middle Adults, 2018-2023.PMC12814403R01 DA001411R01 DA016575R01DA016575R01DA001411Terry-McElrath YMPatrick MEfalseMedical Cannabis Use Across Ages 19-65 Years: U.S. Young and Middle Adults, 2018-2023.<h4>Introduction</h4>This study provides national data on cannabis use type (medical versus recreational only) across individuals aged 19-65 years and associations with overall cannabis use prevalence and frequency, including developmental and historical trends and sociodemographic and policy associations.<h4>Methods</h4>Data collected in 2018-2023 from individuals (N=33,647) aged 19-65 years participating in the Monitoring the Future Panel study were analyzed in 2024-2025. Developmental and historical trends and regression analyses examined past 12-month cannabis use type: no use, recreational-only use, or any medical cannabis used from their own written medical recommendation/prescription (with or without recreational use).<h4>Results</h4>Medical use was reported by 2.6% (2.3%, 2.8%) of 2026-01-01T00:00:00Z2026 Mar2026-07-16T06:46:52.459Z2026-07-09T10:41:46.399ZS-EPMC128144034072114510.1016/j.amepre.2025.107994